FB2024_03 , released June 25, 2024
Allele: Dmel\GLazEP2383
Open Close
General Information
Symbol
Dmel\GLazEP2383
Species
D. melanogaster
Name
FlyBase ID
FBal0193459
Feature type
allele
Associated gene
Associated Insertion(s)
Carried in Construct
Also Known As
EP2383
Key Links
Genomic Maps

Allele class
Mutagen
    Nature of the Allele
    Allele class
    Mutagen
    Progenitor genotype
    Associated Insertion(s)
    Cytology
    Description

    The insertion in P{EP}GLazEP2383 is 1.5kb upstream of GLaz.

    Allele components
    Component
    Use(s)
    Mutations Mapped to the Genome
    Curation Data
    Variant Molecular Consequences
    Associated Sequence Data
    DNA sequence
    Protein sequence
     
    Expression Data
    Reporter Expression
    Additional Information
    Statement
    Reference
     
    Marker for
    Reflects expression of
    Reporter construct used in assay
    Human Disease Associations
    Disease Ontology (DO) Annotations
    Models Based on Experimental Evidence ( 0 )
    Disease
    Evidence
    References
    Modifiers Based on Experimental Evidence ( 0 )
    Disease
    Interaction
    References
    Comments on Models/Modifiers Based on Experimental Evidence ( 0 )
     
    Disease-implicated variant(s)
     
    Phenotypic Data
    Phenotypic Class
    Phenotype Manifest In
    Detailed Description
    Statement
    Reference

    GLazEP2383 induction, under the control of Scer\GAL4da.G32 results in greater resistance to hyperoxia.

    GLazEP2383 induction, under the control of Scer\GAL4da.G32 leads to an increase in mean lifespan at 29oC of 18%.

    Expression of GLazEP2383, under the control of Scer\GAL4D42, Scer\GAL4Act5C or Scer\GAL4elav-C155 at 29oC does not have any beneficial effect on lifespan, although expression under the control of Scer\GAL4hs.PB gives a notable lifespan extension (21% increase over wild-type).

    Expression of GLazEP2383 in the central nervous system and some muscles, under the control of Scer\GAL412.1 at 29oC results in an 18% increase in lifespan.

    Expression of GLazEP2383 in the central nervous system and some muscles, under the control of Scer\GAL4109(2)80 at 29oC results in an 29% increase in lifespan.

    Expression of GLazEP2383 in the fat and some muscles, under the control of Scer\GAL4Lk6-DJ634 at 29oC results in an 17% increase in lifespan.

    Expression of GLazEP2383 in the fat and some muscles, under the control of Scer\GAL4how-24B at 29oC results in an 10% increase in lifespan.

    Expression of GLazEP2383 in the eye and salivary glands, under the control of Scer\GAL4GMR.PF at 29oC results in an 22% increase in lifespan.

    External Data
    Interactions
    Show genetic interaction network for Enhancers & Suppressors
    Phenotypic Class
    Phenotype Manifest In
    Additional Comments
    Genetic Interactions
    Statement
    Reference
    Xenogenetic Interactions
    Statement
    Reference
    Complementation and Rescue Data
    Comments
    Images (0)
    Mutant
    Wild-type
    Stocks (0)
    Notes on Origin
    Discoverer
    External Crossreferences and Linkouts ( 0 )
    Synonyms and Secondary IDs (2)
    Reported As
    Symbol Synonym
    GLazEP2383
    Name Synonyms
    Secondary FlyBase IDs
      References (3)